SS-31 (elamipretide) and MOTS-c both target mitochondria but work in opposite directions. SS-31 is a lab-designed peptide that binds cardiolipin in the inner mitochondrial membrane to stabilize the energy machinery. MOTS-c is a natural peptide encoded by mitochondrial DNA that signals outward to the rest of the cell. SS-31 has gone through human clinical trials, while most MOTS-c research is still in cell and animal models.
The Short Answer: Structural Stabilizer vs Cellular Messenger
SS-31 works on mitochondria from the inside. MOTS-c sends messages from mitochondria to the rest of the body. That is the core difference, and most other differences follow from it.
SS-31 is a synthetic four-amino-acid peptide. It moves into mitochondria, attaches to a fat called cardiolipin, and helps keep the inner membrane, where ATP is made, organized and efficient. Think of it as a structural repair crew working at the power plant.
MOTS-c is a 16-amino-acid peptide your own mitochondrial DNA produces. It leaves the mitochondria and acts as a signal. It influences how cells handle glucose, respond to stress, and adapt to exercise. Think of it as the power plant reporting to headquarters and changing company policy.
The evidence gap matters just as much. SS-31 has decades of development and multiple human trials behind it. MOTS-c is a younger discovery, and most of its data comes from mice and cell cultures. For deeper single-peptide profiles, see our guides to elamipretide (SS-31) and MOTS-c.
What SS-31 (Elamipretide) Is and How It Targets Cardiolipin
SS-31 is a mitochondria-targeted tetrapeptide that binds cardiolipin, a phospholipid found almost only in the inner mitochondrial membrane. It was developed by researchers Hazel Szeto and Peter Schiller, which is where the SS name comes from. Its drug-development name is elamipretide.
Cardiolipin matters because it acts as scaffolding for the electron transport chain, the series of protein complexes that turn food-derived electrons into ATP. Cardiolipin helps hold the inner membrane in its folded shape (the cristae) and keeps those complexes grouped so electrons pass efficiently. When cardiolipin is oxidized or damaged, research suggests the chain leaks more electrons, makes more reactive oxygen species, and produces energy less efficiently.
SS-31's proposed mechanism:
- Selective uptake: its alternating positive charges and aromatic residues let it cross membranes and concentrate in the inner mitochondrial membrane.
- Cardiolipin binding: it interacts with cardiolipin and may protect it from oxidative damage.
- Structural support: preclinical work suggests it helps maintain cristae structure and electron transport efficiency.
- Reduced oxidative leak: by supporting tighter electron flow, it is studied for lowering mitochondrial reactive oxygen species at the source.
SS-31 is not mainly an antioxidant that mops up free radicals after they form. It is designed to improve the conditions that create them.
What MOTS-c Is and How Mitochondrial-Derived Signaling Works
MOTS-c is a mitochondrial-derived peptide, a short protein encoded within mitochondrial DNA rather than the cell nucleus. It was first described in 2015 by researchers at the University of Southern California. Its gene sits inside the region of mitochondrial DNA that codes for 12S ribosomal RNA.
The discovery changed how scientists think about mitochondria. They were long viewed as power plants that take orders from the nucleus. MOTS-c showed they can also send orders back. Research suggests MOTS-c influences metabolism through several routes:
- AMPK activation: MOTS-c is studied for activating AMPK, the cell's main energy sensor, which promotes glucose uptake and fat use.
- Folate cycle effects: early work linked it to changes in folate-methionine metabolism that feed into AMPK signaling.
- Nuclear signaling under stress: in cell studies, MOTS-c moved into the nucleus during metabolic stress and affected the expression of stress-response genes.
- Exercise link: studies report that circulating MOTS-c rises with exercise, which is why it is sometimes called an exercise-mimetic signal.
Some research also suggests natural MOTS-c levels fall with age. That observation is the main reason for its longevity interest. A falling level, however, does not prove that adding more reverses aging, and that question has not been tested in humans.
SS-31 vs MOTS-c Side by Side
The quickest way to compare them is by origin, target, and evidence level.
| Feature | SS-31 (Elamipretide) | MOTS-c |
|---|---|---|
| Origin | Synthetic, lab-designed | Natural, encoded by mitochondrial DNA |
| Size | 4 amino acids | 16 amino acids |
| Primary target | Cardiolipin in the inner mitochondrial membrane | Cell-wide signaling (AMPK, nuclear gene expression) |
| Direction of action | Inside mitochondria | Mitochondria outward to cell and body |
| Core role | Structural stabilizer of energy machinery | Metabolic messenger, studied as exercise-mimetic |
| Research stage | Multiple human clinical trials | Mostly preclinical; limited early human work on analogs |
| Legal status as a supplement | Not a dietary supplement | Not a dietary supplement |
The table shows why it is misleading to call these two competitors. They do not do the same job. SS-31 is studied for improving how mitochondria run. MOTS-c is studied for how mitochondria tell the body to adapt. A researcher would choose between them based on the question, not on which one is stronger.
Clinical vs Preclinical: Where the Evidence Actually Stands
SS-31 is a clinical-stage compound. MOTS-c is mostly a preclinical research tool. That is the most important practical difference.
SS-31 / elamipretide: It has been studied in randomized, placebo-controlled human trials by Stealth BioTherapeutics, given by injection under medical supervision. Trials have looked at rare inherited mitochondrial conditions and at heart-, muscle-, and eye-related research. Results have been mixed. Some trials missed their primary endpoints, while other findings were encouraging enough to keep development going, including regulatory activity for a rare inherited mitochondrial condition. Because that status keeps changing, check current FDA records rather than relying on any blog, including this one.
MOTS-c: The strongest data comes from rodent studies. In mice, MOTS-c has been studied for effects on insulin sensitivity, physical capacity in older animals, and metabolic responses to high-fat diets. Human data is mostly observational, such as measuring natural MOTS-c levels in blood. A modified MOTS-c analog entered early-phase human testing, but that is not the same molecule sold online, and early-phase trials are designed to check safety, not to prove benefit.
In short, SS-31 has real human data with honest, mixed results. MOTS-c has promising animal data and little controlled human evidence.
What the Research Does Not Show Yet
Neither peptide has been shown to extend human lifespan, and no trial has tested either one for healthy aging in healthy people. This is the gap most online content skips.
Specific open questions:
- Long-term safety: human SS-31 trials ran for limited periods in specific patient groups. Long-term use in healthy adults has not been studied. For MOTS-c, controlled human safety data is very limited.
- Translation from mice: effects on endurance and metabolism in rodents often shrink or disappear in humans. MOTS-c has not cleared that hurdle.
- Real-world products: clinical trials used pharmaceutical-grade material with verified purity. Products sold online as research peptides have no such guarantee.
- Stacking: there is no human research on combining SS-31 and MOTS-c, despite how often the pairing is promoted online.
Being honest about these gaps is not pessimism. Both molecules are scientifically important because they show mitochondria can be targeted directly. That is different from showing they work as longevity tools.
Legal and Safety Reality: Why Neither Is a Supplement
Neither SS-31 nor MOTS-c is a legal dietary supplement ingredient in the United States. Elamipretide is an investigational drug. MOTS-c is mostly sold as a research chemical labeled not for human consumption.
That label matters. Research-use-only vials are not made under dietary supplement manufacturing rules or drug manufacturing rules. Independent testing of gray-market peptides has repeatedly raised concerns about purity, wrong dosing, and contamination. Both peptides are also injected, which adds sterility risks that oral products do not carry.
If you are interested in either compound, the responsible routes are enrolling in a registered clinical trial or talking with a licensed physician who knows current regulations. Treat the gap between a promising mechanism and a safe product as real.
Legal Ways to Support Mitochondrial Energy Today
You can support the same system these peptides target, cellular energy production, with lawful, well-characterized options. These will not reproduce SS-31 or MOTS-c, but they act on related parts of mitochondrial biology.
- Exercise: the most reliable natural MOTS-c trigger documented in research, and a strong signal for building new mitochondria.
- NAD+ support: NAD+ is a coenzyme the electron transport chain depends on, and levels are reported to decline with age. Precursors such as NMN are studied for supporting NAD+ levels. Ageless Humans NAD+ and NMN supplements are built around this pathway.
- Electron transport support: methylene blue has been studied for its ability to act as an alternative electron carrier within mitochondria, supporting cellular energy production. See our methylene blue capsules.
- Sleep, protein, and metabolic health basics: these shape mitochondrial quality more than any single compound.
Every Ageless Humans product is made in our FDA-registered facility in Carlsbad, California, and every lot is third-party lab tested with a COA. That is the opposite of a research-use-only vial. Follow label directions and check with your doctor before starting anything new.
Frequently asked questions
What is the main difference between SS-31 and MOTS-c?+
SS-31 (elamipretide) is a synthetic peptide that binds cardiolipin in the inner mitochondrial membrane to help stabilize the energy-making machinery. MOTS-c is a natural peptide encoded by mitochondrial DNA that acts as a signal, influencing metabolism through pathways such as AMPK. SS-31 works on mitochondria from the inside, while MOTS-c carries messages from mitochondria to the rest of the cell.
Is SS-31 or MOTS-c better for longevity?+
Neither has been shown to extend lifespan or support healthy aging in human trials, so there is no evidence-based winner. SS-31 has more human data, from clinical trials in specific patient groups, with mixed results. MOTS-c has promising animal research but little controlled human evidence. They also do different jobs, so they are not direct substitutes.
Has elamipretide been tested in humans?+
Yes. Elamipretide (SS-31) has been studied in multiple randomized, placebo-controlled human trials, mainly in people with rare inherited mitochondrial conditions and in heart- and muscle-related research. Results have been mixed, and its regulatory status has been changing, so current FDA records are the best source. It has not been studied as a longevity product in healthy adults.
Is MOTS-c a supplement?+
No. MOTS-c is not a legal dietary supplement ingredient in the United States. It is mostly sold online as a research chemical labeled not for human consumption, which means it is not made to supplement or drug manufacturing standards. Most MOTS-c research has been done in cells and mice.
Can you take SS-31 and MOTS-c together?+
No human research has studied combining SS-31 and MOTS-c, so there is no evidence on safety or benefit for the pairing. Both are investigational or research-only compounds, usually injected, and products sold online lack verified purity. Anyone considering them should talk to a licensed physician or look into registered clinical trials.
How does exercise relate to MOTS-c?+
Research reports that circulating MOTS-c levels rise during and after exercise, which is why it is often described as an exercise-related signaling peptide. Animal studies suggest it helps muscle adapt to metabolic stress. Regular exercise remains the most reliable, evidence-backed way to support your body's own mitochondrial signaling.
